Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lingzhi Chen"'
Autor:
Yongsheng Gong, Xingxing Chen, Hao Zhou, Tiancheng Dong, Wenhua Ge, Lingzhi Chen, Jie Hu, Xiaofang Fan
Publikováno v:
Life Sciences. 224:177-186
Aims The mechanisms underlying cardiorenal syndromes are complex and not fully understood; Fibrosis seems to be a primary driver of the diseases' pathophysiology. Spironolactone can reduce cardiac or renal fibrosis by inhibiting endothelial-mesenchym
Autor:
Weijian Huang, Zhi-Ting Wang, Gaoshu Zheng, Ling-Yue Sun, Xiang Qu, Xingxing Chen, Hao Zhou, Lingzhi Chen
Publikováno v:
Heart and Vessels. 32:1506-1512
Heart failure (HF) has a significant effect on the prognosis of the patients with atrial fibrillation (AF), and also it is an important risk factor for overall mortality. High molecular weight fibroblast growth factor-2 (Hi-FGF-2) is emerging as a pr
Publikováno v:
Biological & Pharmaceutical Bulletin. 40:960-966
There may be cardio-renal interactions in rats of isoproterenol-induced heart failure, which may be associated with renal fibrosis and endothelial-to-mesenchymal transition (EndMT). Since its discovery, relaxin (RLX) which was regarded as a reproduct
Publikováno v:
Heart and vessels. 34(9)
Relaxin, an emerging biomarker in heart failure, is involved in fibrosis and inflammation. The value of relaxin in predicting recurrence of atrial fibrillation (AF) after radiofrequency catheter ablation (RFCA) is unknown and the subject of this stud
Autor:
Weijian Huang, Xin-Lei Wu, Gaoshu Zheng, Xingxing Chen, Lingzhi Chen, Ling-Yue Sun, Hao Zhou, Xiang Qu
Publikováno v:
Frontiers in Aging Neuroscience
Objective: To explore serum caveolin-3 (Cav-3) levels in patients with atrial fibrillation (AF) and to evaluate the role of Cav-3 as a biomarker for AF and incident heart failure (HF). Methods: Three hundred and five patients were enrolled in the stu
Autor:
Zhan, Gao1, Wenhua, Ge1, Jie, Hu1, Xiang, Qu1, Lingzhi, Chen2, Xue, Xia1, Xing-Xing, Chen1, Qianli, Zhu1, Weijian, Huang1, Hao, Zhou1 wyzh66@126.com
Publikováno v:
Life Sciences. Jul2018, Vol. 204, p15-19. 5p.